Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Hetero USFDA Form 483: Unregistered Test

The USFDA inspection of Hetero Labs Ltd, Unit-IX (FEI: 3009093782), Narasapuram, India, conducted in September

Zydus Recalls Antipsychotic Drug for Nit

Zydus is recalling multiple lots of the antipsychotic drug Chlorpromazine in U.S due to the

Qvents Apps and Tools For QMS and GMP Pr

Qvents provides useful tools for QMS processes – Risk Assessments, Continuous Process Validations, Supply Chain Traceability

Loss of Potency: Accord / Intas Recall H

Accord (Intas) initiated a recall of several lots of Levothyroxine tablets in the US for

Nitrosamine Impurities in Pharmaceutical

Qvents Apps & ToolsNitrosamine and NDSRI Risk Assessment Tools – APIs, Drug Products, Excipients, Water

Supply Chain Traceability of Medicinal P

As per EUGMP requirements, EudraLex, Annex 16: Certification by a Qualified Person and Batch Release,

Continuous Process Verification (CPV) an

Author: Venkiteswaran.T.K The USFDA’s 2011 guidance on process validation advocates a life cycle approach and

Concerns of Beta-lactam Contamination Tr

In March 2025, Glenmark initiated recall of 23 products (148 lots) in US for cGMP

Excipient Risk Assessment: Approach, Tem

Qvents Apps & Tools Access the Excipient Risk Assessment Tool – Click Here According to

Qualification of Inhouse Reference Stand

Authored by: Srinivas Churya This Quality Insight post presents a concise approach for selection and